APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flunixin Meglumine Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Flunixin Meglumine Injection Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchFlunixin Meglumine Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Flunixin Meglumine Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Flunixin Meglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flunixin Meglumine Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Flunixin Meglumine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Flunixin Meglumine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flunixin Meglumine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Flunixin Meglumine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Flunixin Meglumine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Flunixin Meglumine Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Flunixin Meglumine Injection include Wuhan Huisheng Biological Technology Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Zoteis and Virbac Animal Health India Private Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flunixin Meglumine Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flunixin Meglumine Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Flunixin Meglumine Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flunixin Meglumine Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flunixin Meglumine Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flunixin Meglumine Injection sales, projected growth trends, production technology, application and end-user industry.

Flunixin Meglumine Injection Segment by Company

Wuhan Huisheng Biological Technology Co., Ltd.

Shandong Zhongmu Veterinary Medicine Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Qilu Animal Health Products Co., Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

Hebei New Century Pharmaceutical Co., Ltd.

Baimukang Animal Pharmaceutical Co., Ltd.

Zoteis

Virbac Animal Health India Private Limited

Norbrook

MSD Animal Health

Merck Animal Health

Bengal Remedies Limited

Flunixin Meglumine Injection Segment by Type

10ml/Dose

20ml/ Dose

Flunixin Meglumine Injection Segment by Application

Animal muscle pain

Animal febrile disease

Others

Flunixin Meglumine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flunixin Meglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flunixin Meglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flunixin Meglumine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flunixin Meglumine Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flunixin Meglumine Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flunixin Meglumine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10ml/Dose Major Manufacturers Table 3. 20ml/ Dose Major Manufacturers Table 4. Global Flunixin Meglumine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Animal muscle pain Major Manufacturers Table 6. Animal febrile disease Major Manufacturers Table 7. Others Major Manufacturers Table 8. Flunixin Meglumine Injection Industry Trends Table 9. Flunixin Meglumine Injection Industry Drivers Table 10. Flunixin Meglumine Injection Industry Opportunities and Challenges Table 11. Flunixin Meglumine Injection Industry Restraints Table 12. Global Flunixin Meglumine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Flunixin Meglumine Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Flunixin Meglumine Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Flunixin Meglumine Injection Revenue Market Share by Region (2021-2026) Table 16. Global Flunixin Meglumine Injection Revenue Market Share by Region (2027-2032) Table 17. Global Flunixin Meglumine Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Doses) Table 18. Global Flunixin Meglumine Injection Sales by Region (2021-2026) & (K Doses) Table 19. Global Flunixin Meglumine Injection Sales by Region (2027-2032) & (K Doses) Table 20. Global Flunixin Meglumine Injection Sales Market Share by Region (2021-2026) Table 21. Global Flunixin Meglumine Injection Sales Market Share by Region (2027-2032) Table 22. Global Flunixin Meglumine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Flunixin Meglumine Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Flunixin Meglumine Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Flunixin Meglumine Injection Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 27. Global Flunixin Meglumine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Flunixin Meglumine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Flunixin Meglumine Injection Manufacturers, Product Type & Application Table 30. Global Flunixin Meglumine Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Flunixin Meglumine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Flunixin Meglumine Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2026) Table 37. Global Flunixin Meglumine Injection Revenue Market Share by Type (2027-2032) Table 38. Global Flunixin Meglumine Injection Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 39. Global Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 40. Global Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 41. Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2026) Table 42. Global Flunixin Meglumine Injection Sales Market Share by Type (2027-2032) Table 43. Global Flunixin Meglumine Injection Price by Type (2021-2026) & (US$/Dose) Table 44. Global Flunixin Meglumine Injection Price by Type (2027-2032) & (US$/Dose) Table 45. Global Flunixin Meglumine Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2026) Table 49. Global Flunixin Meglumine Injection Revenue Market Share by Application (2027-2032) Table 50. Global Flunixin Meglumine Injection Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 51. Global Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 52. Global Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 53. Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2026) Table 54. Global Flunixin Meglumine Injection Sales Market Share by Application (2027-2032) Table 55. Global Flunixin Meglumine Injection Price by Application (2021-2026) & (US$/Dose) Table 56. Global Flunixin Meglumine Injection Price by Application (2027-2032) & (US$/Dose) Table 57. Wuhan Huisheng Biological Technology Co., Ltd. Company Information Table 58. Wuhan Huisheng Biological Technology Co., Ltd. Business Overview Table 59. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 60. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 61. Wuhan Huisheng Biological Technology Co., Ltd. Recent Development Table 62. Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information Table 63. Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview Table 64. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 65. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 66. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development Table 67. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 68. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 69. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 70. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 71. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development Table 72. Qilu Animal Health Products Co., Ltd. Company Information Table 73. Qilu Animal Health Products Co., Ltd. Business Overview Table 74. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 75. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 76. Qilu Animal Health Products Co., Ltd. Recent Development Table 77. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information Table 78. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview Table 79. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 80. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 81. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development Table 82. Hebei New Century Pharmaceutical Co., Ltd. Company Information Table 83. Hebei New Century Pharmaceutical Co., Ltd. Business Overview Table 84. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 85. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 86. Hebei New Century Pharmaceutical Co., Ltd. Recent Development Table 87. Baimukang Animal Pharmaceutical Co., Ltd. Company Information Table 88. Baimukang Animal Pharmaceutical Co., Ltd. Business Overview Table 89. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 90. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 91. Baimukang Animal Pharmaceutical Co., Ltd. Recent Development Table 92. Zoteis Company Information Table 93. Zoteis Business Overview Table 94. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 95. Zoteis Flunixin Meglumine Injection Product Portfolio Table 96. Zoteis Recent Development Table 97. Virbac Animal Health India Private Limited Company Information Table 98. Virbac Animal Health India Private Limited Business Overview Table 99. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 100. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio Table 101. Virbac Animal Health India Private Limited Recent Development Table 102. Norbrook Company Information Table 103. Norbrook Business Overview Table 104. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 105. Norbrook Flunixin Meglumine Injection Product Portfolio Table 106. Norbrook Recent Development Table 107. MSD Animal Health Company Information Table 108. MSD Animal Health Business Overview Table 109. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 110. MSD Animal Health Flunixin Meglumine Injection Product Portfolio Table 111. MSD Animal Health Recent Development Table 112. Merck Animal Health Company Information Table 113. Merck Animal Health Business Overview Table 114. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 115. Merck Animal Health Flunixin Meglumine Injection Product Portfolio Table 116. Merck Animal Health Recent Development Table 117. Bengal Remedies Limited Company Information Table 118. Bengal Remedies Limited Business Overview Table 119. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 120. Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio Table 121. Bengal Remedies Limited Recent Development Table 122. North America Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 125. North America Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 126. North America Flunixin Meglumine Injection Sales Price by Type (2021-2026) & (US$/Dose) Table 127. North America Flunixin Meglumine Injection Sales Price by Type (2027-2032) & (US$/Dose) Table 128. North America Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 131. North America Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 132. North America Flunixin Meglumine Injection Sales Price by Application (2021-2026) & (US$/Dose) Table 133. North America Flunixin Meglumine Injection Sales Price by Application (2027-2032) & (US$/Dose) Table 134. North America Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Flunixin Meglumine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Flunixin Meglumine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 138. North America Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 139. North America Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 140. North America Flunixin Meglumine Injection Sales Price by Country (2021-2026) & (US$/Dose) Table 141. North America Flunixin Meglumine Injection Sales Price by Country (2027-2032) & (US$/Dose) Table 142. United States Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 143. Canada Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 144. Europe Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 147. Europe Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 148. Europe Flunixin Meglumine Injection Sales Price by Type (2021-2026) & (US$/Dose) Table 149. Europe Flunixin Meglumine Injection Sales Price by Type (2027-2032) & (US$/Dose) Table 150. Europe Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 153. Europe Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 154. Europe Flunixin Meglumine Injection Sales Price by Application (2021-2026) & (US$/Dose) Table 155. Europe Flunixin Meglumine Injection Sales Price by Application (2027-2032) & (US$/Dose) Table 156. Europe Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Flunixin Meglumine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Flunixin Meglumine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 160. Europe Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 161. Europe Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 162. Europe Flunixin Meglumine Injection Sales Price by Country (2021-2026) & (US$/Dose) Table 163. Europe Flunixin Meglumine Injection Sales Price by Country (2027-2032) & (US$/Dose) Table 164. Germany Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 165. France Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 166. U.K. Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 167. Italy Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 169. China Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 170. China Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 171. China Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 172. China Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 173. China Flunixin Meglumine Injection Sales Price by Type (2021-2026) & (US$/Dose) Table 174. China Flunixin Meglumine Injection Sales Price by Type (2027-2032) & (US$/Dose) Table 175. China Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 176. China Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 177. China Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 178. China Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 179. China Flunixin Meglumine Injection Sales Price by Application (2021-2026) & (US$/Dose) Table 180. China Flunixin Meglumine Injection Sales Price by Application (2027-2032) & (US$/Dose) Table 181. Asia Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 184. Asia Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 185. Asia Flunixin Meglumine Injection Sales Price by Type (2021-2026) & (US$/Dose) Table 186. Asia Flunixin Meglumine Injection Sales Price by Type (2027-2032) & (US$/Dose) Table 187. Asia Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 190. Asia Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 191. Asia Flunixin Meglumine Injection Sales Price by Application (2021-2026) & (US$/Dose) Table 192. Asia Flunixin Meglumine Injection Sales Price by Application (2027-2032) & (US$/Dose) Table 193. Asia Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Flunixin Meglumine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Flunixin Meglumine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 197. Asia Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 198. Asia Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 199. Asia Flunixin Meglumine Injection Sales Price by Country (2021-2026) & (US$/Dose) Table 200. Asia Flunixin Meglumine Injection Sales Price by Country (2027-2032) & (US$/Dose) Table 201. Japan Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 202. South Korea Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 203. India Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 204. Australia Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 205. China Taiwan Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Flunixin Meglumine Injection Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Flunixin Meglumine Injection Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 210. SAMEA Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 211. SAMEA Flunixin Meglumine Injection Sales Price by Type (2021-2026) & (US$/Dose) Table 212. SAMEA Flunixin Meglumine Injection Sales Price by Type (2027-2032) & (US$/Dose) Table 213. SAMEA Flunixin Meglumine Injection Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Flunixin Meglumine Injection Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 216. SAMEA Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 217. SAMEA Flunixin Meglumine Injection Sales Price by Application (2021-2026) & (US$/Dose) Table 218. SAMEA Flunixin Meglumine Injection Sales Price by Application (2027-2032) & (US$/Dose) Table 219. SAMEA Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Flunixin Meglumine Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Flunixin Meglumine Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 223. SAMEA Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 224. SAMEA Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 225. SAMEA Flunixin Meglumine Injection Sales Price by Country (2021-2026) & (US$/Dose) Table 226. SAMEA Flunixin Meglumine Injection Sales Price by Country (2027-2032) & (US$/Dose) Table 227. Brazil Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 228. Argentina Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 229. Chile Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 230. Colombia Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 231. Peru Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 233. Israel Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 234. UAE Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 235. Turkey Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 236. Iran Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 237. Egypt Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Flunixin Meglumine Injection Distributors List Table 241. Flunixin Meglumine Injection Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Flunixin Meglumine Injection Image Figure 2. Global Flunixin Meglumine Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flunixin Meglumine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10ml/Dose Image Figure 5. 20ml/ Dose Image Figure 6. Global Flunixin Meglumine Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Flunixin Meglumine Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Animal muscle pain Image Figure 9. Animal febrile disease Image Figure 10. Others Image Figure 11. Global Flunixin Meglumine Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Flunixin Meglumine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Flunixin Meglumine Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Flunixin Meglumine Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Flunixin Meglumine Injection Sales (2021-2032) & (K Doses) Figure 17. Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 18. Global Flunixin Meglumine Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Flunixin Meglumine Injection Sales YoY (2021-2032) & (K Doses) Figure 20. Europe Flunixin Meglumine Injection Sales YoY (2021-2032) & (K Doses) Figure 21. China Flunixin Meglumine Injection Sales YoY (2021-2032) & (K Doses) Figure 22. Asia (Excluding China) Flunixin Meglumine Injection Sales YoY (2021-2032) & (K Doses) Figure 23. South America, Middle East and Africa Flunixin Meglumine Injection Sales YoY (2021-2032) & (K Doses) Figure 24. Global Flunixin Meglumine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Flunixin Meglumine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Flunixin Meglumine Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Flunixin Meglumine Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Flunixin Meglumine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 31. Global Flunixin Meglumine Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2032) Figure 33. Global Flunixin Meglumine Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Flunixin Meglumine Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Flunixin Meglumine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 37. Global Flunixin Meglumine Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2032) Figure 39. North America Flunixin Meglumine Injection Revenue Share by Type (2021-2032) Figure 40. North America Flunixin Meglumine Injection Sales Share by Type (2021-2032) Figure 41. North America Flunixin Meglumine Injection Revenue Share by Application (2021-2032) Figure 42. North America Flunixin Meglumine Injection Sales Share by Application (2021-2032) Figure 43. North America Flunixin Meglumine Injection Revenue Share by Country (2021-2032) Figure 44. North America Flunixin Meglumine Injection Sales Share by Country (2021-2032) Figure 45. Europe Flunixin Meglumine Injection Revenue Share by Type (2021-2032) Figure 46. Europe Flunixin Meglumine Injection Sales Share by Type (2021-2032) Figure 47. Europe Flunixin Meglumine Injection Revenue Share by Application (2021-2032) Figure 48. Europe Flunixin Meglumine Injection Sales Share by Application (2021-2032) Figure 49. Europe Flunixin Meglumine Injection Revenue Share by Country (2021-2032) Figure 50. Europe Flunixin Meglumine Injection Sales Share by Country (2021-2032) Figure 51. China Flunixin Meglumine Injection Revenue Share by Type (2021-2032) Figure 52. China Flunixin Meglumine Injection Sales Share by Type (2021-2032) Figure 53. China Flunixin Meglumine Injection Revenue Share by Application (2021-2032) Figure 54. China Flunixin Meglumine Injection Sales Share by Application (2021-2032) Figure 55. Asia Flunixin Meglumine Injection Revenue Share by Type (2021-2032) Figure 56. Asia Flunixin Meglumine Injection Sales Share by Type (2021-2032) Figure 57. Asia Flunixin Meglumine Injection Revenue Share by Application (2021-2032) Figure 58. Asia Flunixin Meglumine Injection Sales Share by Application (2021-2032) Figure 59. Asia Flunixin Meglumine Injection Revenue Share by Country (2021-2032) Figure 60. Asia Flunixin Meglumine Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Flunixin Meglumine Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Flunixin Meglumine Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Flunixin Meglumine Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Flunixin Meglumine Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Flunixin Meglumine Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Flunixin Meglumine Injection Sales Share by Country (2021-2032) Figure 67. Flunixin Meglumine Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Flunixin Meglumine Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml/Dose
  • 20ml/ Dose
Applications
  • Animal muscle pain
  • Animal febrile disease
  • Others
Companies covered
  • Wuhan Huisheng Biological Technology Co., Ltd.
  • Shandong Zhongmu Veterinary Medicine Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Qilu Animal Health Products Co., Ltd.
  • Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  • Hebei New Century Pharmaceutical Co., Ltd.
  • Baimukang Animal Pharmaceutical Co., Ltd.
  • Zoteis
  • Virbac Animal Health India Private Limited
  • Norbrook
  • MSD Animal Health
  • Merck Animal Health
  • Bengal Remedies Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flunixin Meglumine Injection Market by Type
  3. 1.2.1 Global Flunixin Meglumine Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10ml/Dose
  5. 1.2.3 20ml/ Dose
  6. 1.3 Flunixin Meglumine Injection Market by Application
  7. 1.3.1 Global Flunixin Meglumine Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Animal muscle pain
  9. 1.3.3 Animal febrile disease
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Flunixin Meglumine Injection Market Dynamics
  1. 2.1 Flunixin Meglumine Injection Industry Trends
  2. 2.2 Flunixin Meglumine Injection Industry Drivers
  3. 2.3 Flunixin Meglumine Injection Industry Opportunities and Challenges
  4. 2.4 Flunixin Meglumine Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flunixin Meglumine Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flunixin Meglumine Injection Revenue by Region
  3. 3.2.1 Global Flunixin Meglumine Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flunixin Meglumine Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Flunixin Meglumine Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Flunixin Meglumine Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flunixin Meglumine Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flunixin Meglumine Injection Sales by Region
  9. 3.4.1 Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flunixin Meglumine Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Flunixin Meglumine Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Flunixin Meglumine Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flunixin Meglumine Injection Revenue by Manufacturers
  2. 4.1.1 Global Flunixin Meglumine Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flunixin Meglumine Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flunixin Meglumine Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flunixin Meglumine Injection Sales by Manufacturers
  6. 4.2.1 Global Flunixin Meglumine Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flunixin Meglumine Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flunixin Meglumine Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flunixin Meglumine Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flunixin Meglumine Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flunixin Meglumine Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flunixin Meglumine Injection Manufacturers, Product Type & Application
  13. 4.7 Global Flunixin Meglumine Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flunixin Meglumine Injection Market CR5 and HHI
  16. 4.8.2 2025 Flunixin Meglumine Injection Tier 1, Tier 2, and Tier 3
5 Flunixin Meglumine Injection Market by Type
  1. 5.1 Global Flunixin Meglumine Injection Revenue by Type
  2. 5.1.1 Global Flunixin Meglumine Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flunixin Meglumine Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flunixin Meglumine Injection Sales by Type
  6. 5.2.1 Global Flunixin Meglumine Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flunixin Meglumine Injection Sales by Type (2021-2032) & (K Doses)
  8. 5.2.3 Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flunixin Meglumine Injection Price by Type
6 Flunixin Meglumine Injection Market by Application
  1. 6.1 Global Flunixin Meglumine Injection Revenue by Application
  2. 6.1.1 Global Flunixin Meglumine Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flunixin Meglumine Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flunixin Meglumine Injection Sales by Application
  6. 6.2.1 Global Flunixin Meglumine Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flunixin Meglumine Injection Sales by Application (2021-2032) & (K Doses)
  8. 6.2.3 Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flunixin Meglumine Injection Price by Application
7 Company Profiles
  1. 7.1 Wuhan Huisheng Biological Technology Co., Ltd.
  2. 7.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
  3. 7.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
  4. 7.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  6. 7.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
  7. 7.2 Shandong Zhongmu Veterinary Medicine Co., Ltd.
  8. 7.2.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
  9. 7.2.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview
  10. 7.2.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  12. 7.2.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
  13. 7.3 Shandong Lukang Pharmaceutical Co., Ltd.
  14. 7.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  18. 7.3.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Qilu Animal Health Products Co., Ltd.
  20. 7.4.1 Qilu Animal Health Products Co., Ltd. Company Information
  21. 7.4.2 Qilu Animal Health Products Co., Ltd. Business Overview
  22. 7.4.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  24. 7.4.5 Qilu Animal Health Products Co., Ltd. Recent Developments
  25. 7.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  26. 7.5.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  30. 7.5.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Hebei New Century Pharmaceutical Co., Ltd.
  32. 7.6.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Hebei New Century Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  36. 7.6.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Baimukang Animal Pharmaceutical Co., Ltd.
  38. 7.7.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Baimukang Animal Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  42. 7.7.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Zoteis
  44. 7.8.1 Zoteis Company Information
  45. 7.8.2 Zoteis Business Overview
  46. 7.8.3 Zoteis Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zoteis Flunixin Meglumine Injection Product Portfolio
  48. 7.8.5 Zoteis Recent Developments
  49. 7.9 Virbac Animal Health India Private Limited
  50. 7.9.1 Virbac Animal Health India Private Limited Company Information
  51. 7.9.2 Virbac Animal Health India Private Limited Business Overview
  52. 7.9.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
  54. 7.9.5 Virbac Animal Health India Private Limited Recent Developments
  55. 7.10 Norbrook
  56. 7.10.1 Norbrook Company Information
  57. 7.10.2 Norbrook Business Overview
  58. 7.10.3 Norbrook Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Norbrook Flunixin Meglumine Injection Product Portfolio
  60. 7.10.5 Norbrook Recent Developments
  61. 7.11 MSD Animal Health
  62. 7.11.1 MSD Animal Health Company Information
  63. 7.11.2 MSD Animal Health Business Overview
  64. 7.11.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
  66. 7.11.5 MSD Animal Health Recent Developments
  67. 7.12 Merck Animal Health
  68. 7.12.1 Merck Animal Health Company Information
  69. 7.12.2 Merck Animal Health Business Overview
  70. 7.12.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
  72. 7.12.5 Merck Animal Health Recent Developments
  73. 7.13 Bengal Remedies Limited
  74. 7.13.1 Bengal Remedies Limited Company Information
  75. 7.13.2 Bengal Remedies Limited Business Overview
  76. 7.13.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
  78. 7.13.5 Bengal Remedies Limited Recent Developments
8 North America
  1. 8.1 North America Flunixin Meglumine Injection Market Size by Type
  2. 8.1.1 North America Flunixin Meglumine Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Flunixin Meglumine Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Flunixin Meglumine Injection Price by Type (2021-2032)
  5. 8.2 North America Flunixin Meglumine Injection Market Size by Application
  6. 8.2.1 North America Flunixin Meglumine Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Flunixin Meglumine Injection Price by Application (2021-2032)
  9. 8.3 North America Flunixin Meglumine Injection Market Size by Country
  10. 8.3.1 North America Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flunixin Meglumine Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Flunixin Meglumine Injection Market Size by Type
  2. 9.1.1 Europe Flunixin Meglumine Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flunixin Meglumine Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Flunixin Meglumine Injection Price by Type (2021-2032)
  5. 9.2 Europe Flunixin Meglumine Injection Market Size by Application
  6. 9.2.1 Europe Flunixin Meglumine Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Flunixin Meglumine Injection Price by Application (2021-2032)
  9. 9.3 Europe Flunixin Meglumine Injection Market Size by Country
  10. 9.3.1 Europe Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flunixin Meglumine Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Flunixin Meglumine Injection Market Size by Type
  2. 10.1.1 China Flunixin Meglumine Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Flunixin Meglumine Injection Sales by Type (2021-2032)
  4. 10.1.3 China Flunixin Meglumine Injection Price by Type (2021-2032)
  5. 10.2 China Flunixin Meglumine Injection Market Size by Application
  6. 10.2.1 China Flunixin Meglumine Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 10.2.3 China Flunixin Meglumine Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flunixin Meglumine Injection Market Size by Type
  2. 11.1.1 Asia Flunixin Meglumine Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flunixin Meglumine Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Flunixin Meglumine Injection Price by Type (2021-2032)
  5. 11.2 Asia Flunixin Meglumine Injection Market Size by Application
  6. 11.2.1 Asia Flunixin Meglumine Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Flunixin Meglumine Injection Price by Application (2021-2032)
  9. 11.3 Asia Flunixin Meglumine Injection Market Size by Country
  10. 11.3.1 Asia Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flunixin Meglumine Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flunixin Meglumine Injection Market Size by Type
  2. 12.1.1 SAMEA Flunixin Meglumine Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flunixin Meglumine Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flunixin Meglumine Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Flunixin Meglumine Injection Market Size by Application
  6. 12.2.1 SAMEA Flunixin Meglumine Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flunixin Meglumine Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Flunixin Meglumine Injection Market Size by Country
  10. 12.3.1 SAMEA Flunixin Meglumine Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flunixin Meglumine Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flunixin Meglumine Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flunixin Meglumine Injection Value Chain Analysis
  2. 13.1.1 Flunixin Meglumine Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flunixin Meglumine Injection Production Mode & Process
  6. 13.2 Flunixin Meglumine Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flunixin Meglumine Injection Distributors
  9. 13.2.3 Flunixin Meglumine Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst